Efficacy of a nitric oxide–releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts

C Leonetti, M Scarsella, G Zupi, W Zoli… - Molecular cancer …, 2006 - AACR
We previously showed that NCX 4040 inhibits in vitro and in vivo tumor growth and induces
apoptosis in human colon cancer cell lines. On the basis of these results, NCX 4040 …

Targeting aldose reductase for the treatment of cancer

R Tammali, SK Srivastava… - Current cancer drug …, 2011 - ingentaconnect.com
It is strongly established by numerous studies that oxidative stress-induced inflammation is
one of the major causative agents in a variety of cancers. Various factors such as bacterial …

Molecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic target

EA Grimm, AG Sikora, S Ekmekcioglu - Clinical Cancer Research, 2013 - AACR
It is widely accepted that many cancers express features of inflammation, driven by both
microenvironmental cells and factors, and the intrinsic production of inflammation …

Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDs …

JL Williams, S Borgo, I Hasan, E Castillo, F Traganos… - Cancer Research, 2001 - AACR
Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NO-NSAIDs), consisting of a
known nonsteroidal anti-inflammatory drug (NSAID) and a nitric oxide (NO)-releasing group …

Redox homeostasis and metabolism in cancer: a complex mechanism and potential targeted therapeutics

A Ghoneum, AY Abdulfattah, BO Warren, J Shu… - International journal of …, 2020 - mdpi.com
Reactive Oxygen Species or “ROS” encompass several molecules derived from oxygen that
can oxidize other molecules and subsequently transition rapidly between species. The key …

Novel 1, 4-benzothazines obliterate COX-2 mediated JAK-2/STAT-3 signals with potential regulation of oxidative and metabolic stress during colorectal cancer

A Rai, U Kumar, V Raj, AK Singh, P Kumar… - Pharmacological …, 2018 - Elsevier
benzothiazines have ameliorative effects through inhibition of COX-2 mediated STAT-3
pathways at G-protein couple receptor site. As per this scenario, we recently prepared and …

l-Arginine Reduces Cell Proliferation and Ornithine Decarboxylase Activity in Patients with Colorectal Adenoma and Adenocarcinoma

Q Ma, Y Wang, X Gao, Z Ma, Z Song - Clinical cancer research, 2007 - AACR
Purpose: Evidence suggests that the majority of colorectal carcinomas arise from adenomas,
and l-arginine suppresses colorectal tumorigenesis. We suppose that l-arginine may inhibit …

The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia

B Rigas - Current opinion in gastroenterology, 2007 - journals.lww.com
The use of nitric oxide-donating nonsteroidal anti-inflammat... : Current Opinion in
Gastroenterology The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the …

The anti-inflammatory drug dimethyl itaconate protects against colitis-associated colorectal cancer

Q Wang, XL Li, Y Mei, JC Ye, W Fan, GH Cheng… - Journal of Molecular …, 2020 - Springer
Colorectal cancer (CRC) is the third most common diagnosed cancer of which risk factors
include unhealthy diet, smoking, and chronic inflammation. Weakening the inflammatory …

Identification of nitric oxide-releasing derivatives of oleanolic acid as potential anti-colon cancer agents

J Fu, Y Zou, Z Huang, C Yan, Q Zhou, H Zhang, Y Lai… - RSC Advances, 2015 - pubs.rsc.org
A group of nitric oxide (NO)-releasing derivatives of oleanolic acid (OA)(5–13) were
designed, synthesized and biologically evaluated for their anti-colon cancer activity. It was …